Literature DB >> 24560417

Ascending aorta dilation in association with bicuspid aortic valve: a maturation defect of the aortic wall.

Nimrat Grewal1, Adriana C Gittenberger-de Groot2, Robert E Poelmann3, Robert J M Klautz4, Johannes H N Lindeman5, Marie-José Goumans6, Meindert Palmen4, Salah A Mohamed7, Hans-Hinrich Sievers7, Ad J J C Bogers8, Marco C DeRuiter9.   

Abstract

OBJECTIVE: Patients with a bicuspid aortic valve have increased susceptibility to the development of ascending aortic dilation and dissection compared with persons with a tricuspid valve. To unravel a possible different mechanism underlying dilation in bicuspidy and tricuspidy, a comparison of the structure of the aortic wall was made.
METHODS: Ascending aortic wall biopsies were divided into 4 groups: bicuspid (n=36) and tricuspid (n=23) without and with dilation. The expression of vascular smooth muscle cell maturation markers including lamin A/C, which plays a pivotal role in smooth muscle cell differentiation, and its splicing variant progerin indicative of aging, were studied immunohistochemically. Attention was also paid to the inflammatory status.
RESULTS: There is a significant difference in the structure and maturation of the aortic wall in bicuspidy, persisting in the dilated aortic wall, presenting with a thinner intima, lower expression of α smooth muscle actin, smooth muscle 22α, calponin, and almost absent expression of smoothelin. We show for the first time significantly lowered lamin A/C expression in bicuspidy. Progerin was found to be significantly increased in the media of the dilated wall in tricuspidy, also showing increased periaortic inflammation.
CONCLUSIONS: The structure of the nondilated and dilated aortic wall in bicuspidy and tricuspidy are intrinsically different, with the latter having more aspects of aging. In bicuspidy there is a defective smooth muscle cell differentiation possibly linked to lowered lamin A/C expression. Based on this vessel wall immaturity and increased susceptibility to dilation, different diagnostic and therapeutic approaches are warranted.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24560417     DOI: 10.1016/j.jtcvs.2014.01.027

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  27 in total

1.  Late post-AVR progression of bicuspid aortopathy: link to hemodynamics.

Authors:  Shiho Naito; Tatiana Gross; Kushtrim Disha; Yskert von Kodolitsch; Hermann Reichenspurner; Evaldas Girdauskas
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-02-13

2.  Inhibition of the methyltranferase EZH2 improves aortic performance in experimental thoracic aortic aneurysm.

Authors:  Christian L Lino Cardenas; Chase W Kessinger; Carolyn MacDonald; Arminder S Jassar; Eric M Isselbacher; Farouc A Jaffer; Mark E Lindsay
Journal:  JCI Insight       Date:  2018-03-08

Review 3.  Cardiac Neural Crest Cells: Their Rhombomeric Specification, Migration, and Association with Heart and Great Vessel Anomalies.

Authors:  Olivier Schussler; Lara Gharibeh; Parmeseeven Mootoosamy; Nicolas Murith; Vannary Tien; Anne-Laure Rougemont; Tornike Sologashvili; Erik Suuronen; Yves Lecarpentier; Marc Ruel
Journal:  Cell Mol Neurobiol       Date:  2020-05-13       Impact factor: 5.046

4.  In Vitro Lineage-Specific Differentiation of Vascular Smooth Muscle Cells in Response to SMAD3 Deficiency: Implications for SMAD3-Related Thoracic Aortic Aneurysm.

Authors:  Jian Gong; Dong Zhou; Longtan Jiang; Ping Qiu; Dianna M Milewicz; Y Eugene Chen; Bo Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-14       Impact factor: 8.311

Review 5.  Bicuspid aortic valve related aortopathy.

Authors:  Sina Stock; Salah A Mohamed; Hans-Hinrich Sievers
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-08-30

6.  The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version.

Authors:  Michael A Borger; Paul W M Fedak; Elizabeth H Stephens; Thomas G Gleason; Evaldas Girdauskas; John S Ikonomidis; Ali Khoynezhad; Samuel C Siu; Subodh Verma; Michael D Hope; Duke E Cameron; Donald F Hammer; Joseph S Coselli; Marc R Moon; Thoralf M Sundt; Alex J Barker; Michael Markl; Alessandro Della Corte; Hector I Michelena; John A Elefteriades
Journal:  J Thorac Cardiovasc Surg       Date:  2018-08       Impact factor: 5.209

7.  Case 3/2015 A 32-year-old female patient with coarctation of the aorta, bicuspid aortic valve and dilatation of the ascending aorta.

Authors:  Edmar Atik; Raul Arrieta; Roberto Kalil Filho
Journal:  Arq Bras Cardiol       Date:  2015-03-01       Impact factor: 2.000

8.  Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy?

Authors:  Nimrat Grewal; Romy Franken; Barbara J M Mulder; Marie-José Goumans; Johannes H N Lindeman; Monique R M Jongbloed; Marco C DeRuiter; Robert J M Klautz; Ad J J C Bogers; Robert E Poelmann; Adriana C Gittenberger-de Groot
Journal:  Heart Vessels       Date:  2015-07-01       Impact factor: 2.037

Review 9.  Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.

Authors:  Ignacio Benedicto; Beatriz Dorado; Vicente Andrés
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

Review 10.  Aortic Dilatation in Patients With Bicuspid Aortic Valve.

Authors:  Jing Wang; Wenhui Deng; Qing Lv; Yuman Li; Tianshu Liu; Mingxing Xie
Journal:  Front Physiol       Date:  2021-07-06       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.